Wang Yijun,Zhang Lina,Chang Dongshu,Li Hongqi,Wang Yingjie,Xia Tingyi.The therapeutic effect of stereotactic γ-ray body radiation therapy for patients with asynchronous bilateral renal cell carcinoma[J].Chinese Journal of Radiological Medicine and Protection,2014,34(2):125-128
The therapeutic effect of stereotactic γ-ray body radiation therapy for patients with asynchronous bilateral renal cell carcinoma
Received:July 09, 2013  
DOI:10.3760/cma.j.issn.0254-5098.2014.02.012
KeyWords:Renal cell carcinoma  Stereotactic γ-ray body radiation therapy  Asynchronous bilateral tumor
FundProject:
Author NameAffiliationE-mail
Wang Yijun Department of Radiation Oncology, Air Force General Hospital, Beijing 100142, China  
Zhang Lina Department of Radiation Oncology, Air Force General Hospital, Beijing 100142, China  
Chang Dongshu Department of Radiation Oncology, Air Force General Hospital, Beijing 100142, China  
Li Hongqi Department of Radiation Oncology, Air Force General Hospital, Beijing 100142, China  
Wang Yingjie Department of Radiation Oncology, Air Force General Hospital, Beijing 100142, China wangyj9999@163.com 
Xia Tingyi Department of Radiation Oncology, Air Force General Hospital, Beijing 100142, China  
Hits: 3587
Download times: 2323
Abstract::
      Objective To preliminarily evaluate the feasibility, therapeutic effect and normal tissue complications of stereotactic γ-ray body radiation therapy for patients with asynchronous bilateral renal cell carcinoma. Methods Nine patients with inoperable asynchronous bilateral renal cell carcinoma with a median time from the resection of the primary focus and discovery of the contralateral focus underwent stereotactic γ-ray body radiotherapy with OUR-QGD stereotactic γ-ray whole body therapeutic planning system. 50% isodose line, as the prescription dose line, was to cover the planning target volume (PTV) and the 70% isodose line was to cover the gross target volume (GTV). Radiotherapy was delivered, with a single dose of 3-5 Gy per fraction, one fraction per day, 5 fractions per week, and totally 10-17 fractions. The PTV edge total dose was 36-51 Gy, and the GTV edge total dose was 60-85 Gy. The patients were followed up for a median time of 24 months to evaluate the local control rate and overall survival rate. Results Of the 9 patients, 1 presented complete remission (11.1%) and 4 partial remission (44.5%), with a total effective rate of 55.6%. The 1-, 3-, and 5-year local control rates were 64.8%, 43.2%, and 43.2% respectively. The 1-, 3-, and 5-year overall survival rates were 66.7%, 53.3%, and 35.6% respectively. Four patients (44.4%) had acute radiation reaction: 2 cases with grade 1 leukocytopenia and 2 cases with grade 1 gastrointestinal reactions. Two patients showed grade 2 late radiation-induced reaction in gastrointestinal system. The Karnofsky score was significantly increased and the renal function was normal after radiotherapy. Conclusions Stereotactic γ-ray body radiation therapy is safe and effective in the treatment of asynchronous bilateral renal cell carcinoma.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9069531  On-line:0

v
Scan QR Code
&et=5F741B4D21BEB0FB0D5607AC09195ECCAA721AB2AE0A9BEE46F9626F60D03290AA95DC7C05F6A05A7EBB68B5B028173809B024D3FACC353467F25BCDEE2F857C588060B4A76E2D6EA89B0CFE59B5EAD9EE1374F1DD700EAB29163732B9F2072ACDEA8A213CA5BD168D42FDA7826C83A9A376E7541013852542A4086A2D4ECAD8BD0105DD7F37EB9C&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=9EAD63ADE6B277ED&aid=85AF3EE9C4B7D0428A25BCF1EF211654&vid=&iid=0B39A22176CE99FB&sid=F122871CC7EC92DC&eid=1F199509C0B6C4D6&fileno=20140212&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="9EAD63ADE6B277ED"; var my_aid="85AF3EE9C4B7D0428A25BCF1EF211654";